Skip to main content
Grifols S.A. logo

Grifols S.A. — Investor Relations & Filings

Ticker · GRF ISIN · ES0171996087 LEI · 959800HSSNXWRKBK4N60 MC Manufacturing
Open in API
Filings indexed 684 across all filing types
Latest filing 2021-05-31 Transaction in Own Shar…
Country ES Spain
Listing MC GRF

About Grifols S.A.

https://www.grifols.com/en/home

Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.

Recent filings

Filing Released Lang Actions
Información periódica bajo el programa de recompra de acciones
Transaction in Own Shares Classification · 98% confidence The document is a formal communication from Grifols, S.A. to the CNMV (Comisión Nacional del Mercado de Valores), titled 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information). The core content details transactions carried out under a share repurchase program ('programa de recompra de acciones propias') over a specific period (May 26 to May 28, 2021). This type of filing, reporting the company's own transactions in its shares, directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a regulatory filing, the specific nature of reporting share repurchases makes POS the most accurate classification over the general RNS fallback.
2021-05-31 Spanish
Información periódica bajo el programa de recompra de acciones
Transaction in Own Shares Classification · 98% confidence The document is a formal communication from Grifols, S.A. to the Spanish National Securities Market Commission ("Comisión Nacional del Mercado de Valores") under the category "OTRA INFORMACIÓN RELEVANTE" (Other Relevant Information). The core content details transactions carried out under a previously announced share repurchase program ("programa de recompra de acciones propias") during a specific period (May 18 to May 25, 2021). This type of filing, reporting the execution of share buybacks, directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it references regulatory compliance (EU Regulation 2016/1052), the primary subject is the transaction activity itself, not a general regulatory announcement (RNS) or a capital change announcement (SHA).
2021-05-25 Spanish
Motivo de la notificación: Persona con Responsabilidad de Dirección
Director's Dealing Classification · 99% confidence The document is titled "MODELO DE NOTIFICACIÓN DE LAS OPERACIONES DE LAS PERSONAS CON RESPONSABILIDADES DE DIRECCIÓN Y DE LAS PERSONAS ESTRECHAMENTE VINCULADAS CON ELLAS" (Standard Form for Notification and Public Disclosure of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with Them). This form explicitly details transactions (Venta/Sale) conducted by a Director (Victor Grifols Roura, CONSEJERO) of the issuer (GRIFOLS, S.A.). This directly corresponds to the definition of Director's Dealing, which covers reports of personal share transactions by company directors and executives.
2021-05-25 Spanish
FORM 6-K
Regulatory Filings
2021-05-21 English
Junta General Ordinaria 2021.
AGM Information Classification · 99% confidence The document is a formal communication from Grifols, S.A., detailing resolutions passed during its Ordinary General Shareholders' Meeting held on May 21, 2021. Key elements include the approval of annual accounts (for the year ended December 31, 2020), approval of dividend distributions (both preferred and ordinary), approval of the management report, appointment/re-election of auditors (Deloitte and KPMG), changes to the Board of Directors, and delegation of authority for future capital increases. The text explicitly mentions the meeting and the approval of proposals submitted to the shareholders. This content strongly aligns with the materials presented and voted upon at an Annual General Meeting (AGM). While it contains dividend information (DIV) and governance/remuneration elements (CGR/DEF 14A), the overarching context is the formal record of the AGM proceedings and approvals. Therefore, AGM-R (AGM Information) is the most appropriate classification.
2021-05-21 Spanish
Información periódica bajo el programa de recompra de acciones
Transaction in Own Shares Classification · 98% confidence The document is a formal communication from Grifols, S.A. to the Spanish National Securities Market Commission (CNMV), titled 'OTRA INFORMACIÓN RELEVANTE' (Other Relevant Information). The core content details transactions carried out under a share repurchase program ('programa de recompra de acciones propias') over a specific period (May 11 to May 17, 2021). This type of filing, reporting the company's own transactions in its shares, directly corresponds to the definition of 'Transaction in Own Shares' (POS). Although it is a regulatory filing, the specific nature of the content (share repurchase details) makes POS a more precise classification than the general RNS.
2021-05-17 Spanish

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.